Startups
Memo Therapeutics
https://memo-therapeutics.comAntibody discovery and human immune repertoire analysis platform.
Summary
Industry
Investors
- Verve Ventures Series A
- Verve Ventures Series A
- Redalpine Series A
- Zürcher Kantonal Bank Series A
- Vesalius Biocapital Partners Series C
- Swisscanto Private Equity Series C
- Pureos Bioventures Series C
- Adjuvant Capital Series C
- Vesalius Biocapital Partners Unknown
- Verve Ventures Unknown
- Verve Ventures Unknown
- Redalpine Unknown
Full Company Profile
- Access details of the company management, and other intelligence on this company by registering for Seedtable